Global Pharma Analytics Market Research Report 2024

Publication ID:

PB507245237

Publication Date:

July 24, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Pharma analytics refers to the use of data analytics within the pharmaceutical industry to optimize operations and promote innovation. Pharmaceutical companies can use data analytics to accelerate drug discovery and development, improve drug efficacy, enhance safety and risk management and gain insight into target patient populations.Pharmaceutical companies use pharma analytics to improve every step of the drug development and distribution process. From drug discovery and development to securing regulatory approval and distributing drugs to target populations, data analysis plays a huge role in the field of pharmaceutical manufacturing.Pharmacies can incorporate data analytics to improve operations in a multitude of ways, including ensuring compliance, improving efficiency and monitoring inventory. Pharmacies can use data analytics to compare in-house prescription data against DEA and state regulations to verify operating compliance. Data analytics can also help improve overall efficiency by optimizing order fulfillment and decreasing refill time to increase customer satisfaction and company productivity.
The global Pharma Analytics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharma Analytics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Analytics.
Report Scope
The Pharma Analytics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Analytics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Analytics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quest Diagnostics
Unit8
RxDataScience
MarkLogic
IQVIA
JMP
Itransition
Euretos
ValueCentric
Tealium
TIBCO Software
P360(BirdzAI)
Aetion,Inc
Accenture
AspenTech
Prospection
Segment by Type
Drug Research and Development
Pharmaceutical Manufacturing
Supply Chain Management
Marketing Process
Segment by Application
Pharmaceutical Company
Drugstore
Hospital
Patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Analytics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma Analytics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Research and Development
1.2.3 Pharmaceutical Manufacturing
1.2.4 Supply Chain Management
1.2.5 Marketing Process
1.3 Market by Application
1.3.1 Global Pharma Analytics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Drugstore
1.3.4 Hospital
1.3.5 Patients
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma Analytics Market Perspective (2019-2030)
2.2 Pharma Analytics Growth Trends by Region
2.2.1 Global Pharma Analytics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharma Analytics Historic Market Size by Region (2019-2024)
2.2.3 Pharma Analytics Forecasted Market Size by Region (2025-2030)
2.3 Pharma Analytics Market Dynamics
2.3.1 Pharma Analytics Industry Trends
2.3.2 Pharma Analytics Market Drivers
2.3.3 Pharma Analytics Market Challenges
2.3.4 Pharma Analytics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma Analytics Players by Revenue
3.1.1 Global Top Pharma Analytics Players by Revenue (2019-2024)
3.1.2 Global Pharma Analytics Revenue Market Share by Players (2019-2024)
3.2 Global Pharma Analytics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharma Analytics Revenue
3.4 Global Pharma Analytics Market Concentration Ratio
3.4.1 Global Pharma Analytics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma Analytics Revenue in 2023
3.5 Pharma Analytics Key Players Head office and Area Served
3.6 Key Players Pharma Analytics Product Solution and Service
3.7 Date of Enter into Pharma Analytics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma Analytics Breakdown Data by Type
4.1 Global Pharma Analytics Historic Market Size by Type (2019-2024)
4.2 Global Pharma Analytics Forecasted Market Size by Type (2025-2030)
5 Pharma Analytics Breakdown Data by Application
5.1 Global Pharma Analytics Historic Market Size by Application (2019-2024)
5.2 Global Pharma Analytics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharma Analytics Market Size (2019-2030)
6.2 North America Pharma Analytics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharma Analytics Market Size by Country (2019-2024)
6.4 North America Pharma Analytics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma Analytics Market Size (2019-2030)
7.2 Europe Pharma Analytics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharma Analytics Market Size by Country (2019-2024)
7.4 Europe Pharma Analytics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma Analytics Market Size (2019-2030)
8.2 Asia-Pacific Pharma Analytics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharma Analytics Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharma Analytics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma Analytics Market Size (2019-2030)
9.2 Latin America Pharma Analytics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharma Analytics Market Size by Country (2019-2024)
9.4 Latin America Pharma Analytics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma Analytics Market Size (2019-2030)
10.2 Middle East & Africa Pharma Analytics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharma Analytics Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharma Analytics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Detail
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Pharma Analytics Introduction
11.1.4 Quest Diagnostics Revenue in Pharma Analytics Business (2019-2024)
11.1.5 Quest Diagnostics Recent Development
11.2 Unit8
11.2.1 Unit8 Company Detail
11.2.2 Unit8 Business Overview
11.2.3 Unit8 Pharma Analytics Introduction
11.2.4 Unit8 Revenue in Pharma Analytics Business (2019-2024)
11.2.5 Unit8 Recent Development
11.3 RxDataScience
11.3.1 RxDataScience Company Detail
11.3.2 RxDataScience Business Overview
11.3.3 RxDataScience Pharma Analytics Introduction
11.3.4 RxDataScience Revenue in Pharma Analytics Business (2019-2024)
11.3.5 RxDataScience Recent Development
11.4 MarkLogic
11.4.1 MarkLogic Company Detail
11.4.2 MarkLogic Business Overview
11.4.3 MarkLogic Pharma Analytics Introduction
11.4.4 MarkLogic Revenue in Pharma Analytics Business (2019-2024)
11.4.5 MarkLogic Recent Development
11.5 IQVIA
11.5.1 IQVIA Company Detail
11.5.2 IQVIA Business Overview
11.5.3 IQVIA Pharma Analytics Introduction
11.5.4 IQVIA Revenue in Pharma Analytics Business (2019-2024)
11.5.5 IQVIA Recent Development
11.6 JMP
11.6.1 JMP Company Detail
11.6.2 JMP Business Overview
11.6.3 JMP Pharma Analytics Introduction
11.6.4 JMP Revenue in Pharma Analytics Business (2019-2024)
11.6.5 JMP Recent Development
11.7 Itransition
11.7.1 Itransition Company Detail
11.7.2 Itransition Business Overview
11.7.3 Itransition Pharma Analytics Introduction
11.7.4 Itransition Revenue in Pharma Analytics Business (2019-2024)
11.7.5 Itransition Recent Development
11.8 Euretos
11.8.1 Euretos Company Detail
11.8.2 Euretos Business Overview
11.8.3 Euretos Pharma Analytics Introduction
11.8.4 Euretos Revenue in Pharma Analytics Business (2019-2024)
11.8.5 Euretos Recent Development
11.9 ValueCentric
11.9.1 ValueCentric Company Detail
11.9.2 ValueCentric Business Overview
11.9.3 ValueCentric Pharma Analytics Introduction
11.9.4 ValueCentric Revenue in Pharma Analytics Business (2019-2024)
11.9.5 ValueCentric Recent Development
11.10 Tealium
11.10.1 Tealium Company Detail
11.10.2 Tealium Business Overview
11.10.3 Tealium Pharma Analytics Introduction
11.10.4 Tealium Revenue in Pharma Analytics Business (2019-2024)
11.10.5 Tealium Recent Development
11.11 TIBCO Software
11.11.1 TIBCO Software Company Detail
11.11.2 TIBCO Software Business Overview
11.11.3 TIBCO Software Pharma Analytics Introduction
11.11.4 TIBCO Software Revenue in Pharma Analytics Business (2019-2024)
11.11.5 TIBCO Software Recent Development
11.12 P360(BirdzAI)
11.12.1 P360(BirdzAI) Company Detail
11.12.2 P360(BirdzAI) Business Overview
11.12.3 P360(BirdzAI) Pharma Analytics Introduction
11.12.4 P360(BirdzAI) Revenue in Pharma Analytics Business (2019-2024)
11.12.5 P360(BirdzAI) Recent Development
11.13 Aetion,Inc
11.13.1 Aetion,Inc Company Detail
11.13.2 Aetion,Inc Business Overview
11.13.3 Aetion,Inc Pharma Analytics Introduction
11.13.4 Aetion,Inc Revenue in Pharma Analytics Business (2019-2024)
11.13.5 Aetion,Inc Recent Development
11.14 Accenture
11.14.1 Accenture Company Detail
11.14.2 Accenture Business Overview
11.14.3 Accenture Pharma Analytics Introduction
11.14.4 Accenture Revenue in Pharma Analytics Business (2019-2024)
11.14.5 Accenture Recent Development
11.15 AspenTech
11.15.1 AspenTech Company Detail
11.15.2 AspenTech Business Overview
11.15.3 AspenTech Pharma Analytics Introduction
11.15.4 AspenTech Revenue in Pharma Analytics Business (2019-2024)
11.15.5 AspenTech Recent Development
11.16 Prospection
11.16.1 Prospection Company Detail
11.16.2 Prospection Business Overview
11.16.3 Prospection Pharma Analytics Introduction
11.16.4 Prospection Revenue in Pharma Analytics Business (2019-2024)
11.16.5 Prospection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Quest Diagnostics
Unit8
RxDataScience
MarkLogic
IQVIA
JMP
Itransition
Euretos
ValueCentric
Tealium
TIBCO Software
P360(BirdzAI)
Aetion,Inc
Accenture
AspenTech
Prospection

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂